首页> 外文OA文献 >Tumor-derived exosomes: potential biomarker or therapeutic target in breast cancer?
【2h】

Tumor-derived exosomes: potential biomarker or therapeutic target in breast cancer?

机译:肿瘤来源的外泌体:乳腺癌的潜在生物标志物或治疗靶点?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Exosomes are released by normal and tumour cells, including those involved in breast cancer, and provide a means of intercellular communications. Exosomes with diameters ranging between 30-150 nm are involved in transferring biological information, via various lipids, proteins, different forms of RNAs, and DNA from one cell to another, and this can result in reprogramming of recipient cell functions. These vesicles are present in all body fluids, e.g., blood plasma/serum, semen, saliva, cerebrospinal fluid, breast milk, and urine. It has been recently reported that these particles are involved in the development and progression of different tumor types, including breast cancer. Furthermore, it has been suggested that exosomes have the potential to be used as drug transporters, or as biomarkers. This review highlights the potential roles of exosomes in normal and breast cancer cells and their potential applications as biomarkers with special focus on their potential applications in treatment of breast cancer.
机译:外泌体由正常细胞和肿瘤细胞(包括与乳腺癌有关的细胞)释放,并提供细胞间通讯的方式。直径在30-150 nm之间的外泌体通过各种脂质,蛋白质,不同形式的RNA和DNA从一种细胞转移到另一种细胞,从而参与了生物学信息的传递,这可能导致受体细胞功能的重新编程。这些囊泡存在于所有体液中,例如血浆/血清,精液,唾液,脑脊液,母乳和尿液。最近有报道说,这些颗粒与包括乳腺癌在内的不同肿瘤类型的发生和发展有关。此外,已经提出外泌体具有用作药物转运蛋白或生物标志物的潜力。这篇综述强调了外泌体在正常和乳腺癌细胞中的潜在作用及其作为生物标志物的潜在应用,特别着重于它们在乳腺癌治疗中的潜在应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号